Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International Symposium
- 1 December 2019
- journal article
- review article
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 38 (6) , 647-656
Abstract
No abstract availableKeywords
Funding Information
- BHF Centre of Research Excellence, Oxford
- Novartis
This publication has 51 references indexed in Scilit:
- Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathyCritical Care, 2013
- Bactericidal Antibiotics Induce Mitochondrial Dysfunction and Oxidative Damage in Mammalian CellsScience Translational Medicine, 2013
- Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for RTherapeutic Drug Monitoring, 2012
- Carbapenem resistance in Enterobacteriaceae: here is the storm!Trends in Molecular Medicine, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trialCritical Care, 2012
- Survival in neutropenic patients with severe sepsis or septic shock*Critical Care Medicine, 2012
- Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumoniaCritical Care, 2011
- Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*Critical Care Medicine, 2010
- Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumoniaEuropean Respiratory Journal, 2008